Compare CMCO & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMCO | VALN |
|---|---|---|
| Founded | 1875 | 2012 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.1M | 495.5M |
| IPO Year | 2002 | 2021 |
| Metric | CMCO | VALN |
|---|---|---|
| Price | $13.42 | $5.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $21.00 | $15.50 |
| AVG Volume (30 Days) | ★ 671.7K | 18.4K |
| Earning Date | 05-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $936,240,000.00 | N/A |
| Revenue This Year | $19.73 | N/A |
| Revenue Next Year | $82.91 | $93.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.27 | N/A |
| 52 Week Low | $11.99 | $5.04 |
| 52 Week High | $24.40 | $12.25 |
| Indicator | CMCO | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 44.32 | 39.11 |
| Support Level | $11.99 | $5.10 |
| Resistance Level | $15.57 | $5.52 |
| Average True Range (ATR) | 0.73 | 0.20 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 32.01 | 14.00 |
Columbus McKinnon Corp is a world'wide designer, manufacturer and marketer of intelligent motion solutions for material handling that move the world forward and improve lives by efficiently and ergonomically moving, lifting, positioning and securing materials. Key products include hoists, crane components, precision conveyor systems, rigging tools, light rail workstations and digital power and motion control systems. These are relevant, professional-grade solutions that solve its customers critical material handling requirements.The Company has one operating and reportable segment. It has presence in United State, Germany, Europe, Middle East, and Africa (Excluding Germany), Canada, Asia Pacific, and Latin America. It has majority of sales from United States.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.